11 research outputs found

    AMGA Activity and Future Plan for Belle II

    Get PDF

    The Study of AMGA RAP-based Web Application

    Get PDF
    The ARDA Metadata Catalog Grid Application (AMGA) web application has been widely used; however, it has drawbacks such as easy-to-use interface, no direct building of the Virtual Organization Membership Service (VOMS) proxy and no maintenance after AMGA server version 1.3. In response, we adapted a new development procedure and toolkit from Graphic User Interface (GUI) client, a Client/Server (C/S) program, to a web application to manage the both Eclipse Rich Client Platform (RCP) and Rich Ajax Platform (RAP) at the same time. The AMGA web application provides many interesting features for manipulation of collections, metadata schema, entries, access control, user/group information, federation and others. Additionally, this web application includes a powerful SQL query editor that enables users to make complicated sentences under specific query conditions. In this paper, we describe the implementation of the AMGA web application focusing on the transformation of AMGA Manager using Eclipse RCP to a RAP-based web application

    Time-Shared TMR for Fault-Tolerant Cordic Processors

    No full text
    This paper presents a low-cost approach to concurrent error correction in high-performance CORDIC processors by using time-shared triple modular redundancy. Operands are partitioned into three sets of disjoint digits and operations are performed three times on different hardware components to correct possible errors by majority voting. The approach has limited latency increase and throughput reduction. Pipelining can be used to maintain the same throughput as a conventional design

    β-Peltoboykinolic Acid from Astilbe rubra Attenuates TGF-β1-Induced Epithelial-to-Mesenchymal Transitions in Lung Alveolar Epithelial Cells

    No full text
    Epithelial-to-mesenchymal transition (EMT) is increasingly recognized as contributing to the pathogenesis of idiopathic pulmonary fibrosis. Therefore, novel plant-based natural, active compounds have been sought for the treatment of fibrotic EMT. The aim of the present study was to investigate the inhibitory effects of Astilbe rubra on TGF-β1-induced EMT in lung alveolar epithelial cells (A549). A. rubra was subjected to extraction using 70% ethanol (ARE), and ethanol extracts of the aerial part and that of the rhizome were further partitioned using various solvents. Protein expression and cell motility were investigated to evaluate the inhibitory effects of ARE on EMT. EMT occurred in A549 cells treated with TGF-β1, but was prevented by co-treatment with ARE. The dichloromethane fractions showed the strongest inhibitory effect on TGF-β1-induced EMT. β-Peltoboykinolic acid was isolated from the dichloromethane fractions of A. rubra by activity-oriented isolation. β-Peltoboykinolic acid not only attenuated TGF-β1-induced EMT, but also the overproduction of extracellular matrix components including type I collagen and fibronectin. The Smad pathway activated by TGF-β1 was inhibited by co-treatment with β-peltoboykinolic acid. Taken together, these results indicate that β-peltoboykinolic acid from A. rubra and dichloromethane fractions shows potential as an antifibrotic agent in A549 cells treated with TGF-β1

    Isolation and Characterization of Phenylpropanoid and Lignan Compounds from Peperomia pellucida [L.] Kunth with Estrogenic Activities

    No full text
    Extracts of Peperomia pellucida [L.] Kunth have previously been demonstrated to have in vivo estrogenic-like effects, thereby functioning as an anti-osteoporotic agent. However, the compounds responsible for these effects have not yet been determined. Therefore, the aim of this study is to isolate and elucidate potential compounds with estrogenic activity. The structures of the isolated compounds were identified using 1D 1H and 13C-NMR and confirmed by 2D FT-NMR. The estrogenic activity was evaluated using the E-SCREEN assay, and a molecular docking study was performed to predict the binding affinity of the isolated compounds to estrogen receptors. In this experiment, we successfully isolated three phenylpropanoids and two lignan derivatives, namely, 6-allyl-5-methoxy-1,3-benzodioxol-4-ol (1), pachypostaudin B (2), pellucidin A (3), dillapiole (4), and apiol (5). Among these compounds, the isolation of 1 and 2 from P. pellucida is reported for the first time in this study. Activity assays clearly showed that the ethyl acetate extract and its fractions, subfractions, and isolated compounds exerted estrogenic activity. Methanol fraction of the ethyl acetate extract produced the highest estrogenic activity, while 1 and 2 had partial agonist activity. Some compounds (derivates of dillapiole and pellucidin A) also had, in addition, anti-estrogenic activity. In the docking study, the estrogenic activities of 1–5 appeared to be mediated by a classical ligand-dependent mechanism as suggested by the binding interaction between the compounds and estrogen receptors; binding occurred on Arg 394 and His 524 of the alpha receptor and Arg 346 and His 475 of the beta receptor. In summary, we reveal that P. pellucida is a promising anti-osteoporotic agent due to its estrogenic activity, and the compounds responsible for this activity were found to be lignan and phenylpropanoid derivatives. The presence of other compounds in either the extract or fraction may contribute to a synergistic effect, as suggested by the higher estrogenic activity of the methanol fraction. Hence, we suggest further research on the osteoporotic activity and safety of the identified compounds, especially regarding their effects on estrogen-responsive organs

    The PRAGMA testbed - building a multi-application international grid

    No full text
    This practices and experience paper describes the coordination, design, implementation, availability, and performance of the Pacific Rim Applications and Grid Middleware Assembly (PRAGMA) Grid Testbed. Applications in high-energy physics, genome annotation, quantum computational chemistry, wildfire simulation, and protein sequence alignment have driven the middleware requirements, and the testbed provides a mechanism for international users to share software beyond the essential, de facto standard Globus core. In this paper, we describe how human factors, resource availability and performance issues have affected the middleware, applications and the testbed design. We also describe how middleware components in grid monitoring, grid accounting, grid Remote Procedure Calls, grid-aware file systems, and grid-based optimization have dealt with some of the major characteristics of our testbed. We also briefly describe a number of mechanisms that we have employed to make software more easily available to testbed administrators
    corecore